Company Filing History:
3 out of 61 
2 out of 932 
1 out of 1 Years Active: 2018-2021
Title: Kuo-shyan Lin: Innovator in Cancer Imaging and Treatment
Introduction
Kuo-shyan Lin is a prominent inventor based in Surrey, Canada, known for his significant contributions to the field of cancer imaging and treatment. With a total of four patents to his name, Lin has focused on developing novel compounds that target specific cancer markers, particularly in prostate cancer.
Latest Patents
One of Lin's latest patents involves the development of 18/19F-labelled compounds that target the prostate-specific membrane antigen (PSMA). This disclosure relates to innovative compounds that include a zwitterionic trifluoroborate prosthetic group aimed at PSMA, which is crucial in prostate cancer treatment. The compounds are characterized by a specific formula where each R1 represents an anionic group, L serves as a linker, and R2B-F3 is a pyridinium group or an azole group substituted with methyl BF3. Additionally, Lin has developed compositions and methods for imaging cancer using somatostatin derivative compounds that can be labelled with the isotope fluorine-18. These compounds are designed to have high affinity and selectivity for cellular somatostatin receptors, making them valuable as radioactive tracers in various in vivo imaging applications, including positron emission tomography (PET).
Career Highlights
Throughout his career, Kuo-shyan Lin has worked with esteemed institutions such as the British Columbia Cancer Agency and the University of British Columbia. His work has significantly advanced the understanding and treatment of cancers, particularly through innovative imaging techniques.
Collaborations
Lin has collaborated with notable professionals in his field, including Francois Benard and David Perrin. These collaborations have further enhanced the impact of his research and inventions.
Conclusion
Kuo-shyan Lin's contributions to cancer imaging and treatment through his innovative patents highlight his role as a leading inventor in the medical field. His work continues to pave the way for advancements in cancer diagnostics and therapeutics.